Medication adherence in pregnancy - The MAP-C Study
Research type
Research Study
Full title
Medication adherence in pregnancy - the MAP-C Study
IRAS ID
271731
Contact name
Christy Burden
Contact email
Sponsor organisation
North Bristol NHS Trust
Duration of Study in the UK
0 years, 7 months, 31 days
Research summary
Medication non-adherence is defined as taking less than 80% of prescribed doses. Studies have shown that only 17 to 50 percent of women adhere to their prescribed medication(s) for a range of obstetric conditions and chronic diseases in pregnancy. This poses a major health challenge. Broadly two groups of women are prescribed regular medications in pregnancy: those with chronic pre-existing medical conditions and women who commence medication during pregnancy for a pregnancy-induced conditions, for example, pre-eclampsia. This research relates to the former group- women diagnosed with chronic disease prior to pregnancy.
Women with any chronic disease during pregnancy have a higher risk of adverse pregnancy outcomes for both them and their baby. National guidelines for chronic diseases in pregnancy unanimously recommend optimal control of disease, usually through medication use before and during pregnancy to optimise pregnancy outcomes.
This research is a qualitative interview study investigating perceptual and practical barriers and facilitators to medication adherence in pregnant, post-natal and pre-pregnant women with chronic diseases. We will recruit these women from the maternal medicine clinic, and from outpatient clinics where they are usually managed, and interview them in person or by telephone.
REC name
London - Westminster Research Ethics Committee
REC reference
20/LO/0441
Date of REC Opinion
20 May 2020
REC opinion
Favourable Opinion